Comparison of conventional and enhanced mass resolution triple‐quadrupole mass spectrometers for discovery bioanalytical applications

Abstract

A new triple‐quadrupole mass spectrometry (MS) system with enhanced resolution capabilities has recently become available. In order to evaluate the performance of this new instrument for drug discovery assays, both the linearity and the limit of detection were compared in the positive electrospray ionization (ESI) mode with those of a conventional triple‐quadrupole instrument supplied by the same manufacturer. For these studies, spiked mouse plasma standard samples were split and assayed by each instrument, which allowed for a direct comparison of the two systems. In the unit mass resolution mode, the new mass spectrometer was found to be at least ten‐fold more sensitive than the conventional instrument. The sensitivity of the new mass spectrometer under the enhanced mass resolution mode was found to be even better by another factor of two. For the test compound, the linear dynamic range was found to be 0.05–5000 ng/mL for the new instrument as compared with 2.5–5000 ng/mL for the conventional mass spectrometer. Copyright © 2003 John Wiley & Sons, Ltd.